SCHEMBL23155100

SCHEMBL23155100

CCCCCc1cc(O)c([C@@H]2C=C(C)CC[C@H]2C)c(O)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 14/20 0.72
CNR1 P21554 11/20 0.72
OPRM1 P35372 5/20 0.72
TRPV1 Q8NER1 3/20 0.72
TRPM8 Q7Z2W7 3/20 0.72
GPR55 Q9Y2T6 3/20 0.72
NR1I2 O75469 2/20 0.72
LDHA P00338 2/20 0.72
CYP1A1 P04798 2/20 0.72
CYP2D6 P10635 2/20 0.72
CYP2B6 P20813 2/20 0.72
SLC6A2 P23975 2/20 0.72
CYP2C19 P33261 2/20 0.72
SLC6A3 Q01959 2/20 0.72
ACE2 Q9BYF1 2/20 0.72
MLNR O43193 1/20 0.72
PDE9A O76083 1/20 0.72
ABCB11 O95342 1/20 0.72
CYP1A2 P05177 1/20 0.72
CHRM2 P08172 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24625819 0.99 CNR2 (0.72) CNR2CNR1OPRM1TRPV1TRPM8
SCHEMBL24168943 0.91 CNR2 (0.70) CNR2CNR1OPRM1TRPV1TRPM8
SCHEMBL20192227 0.87 CNR2 (0.69) CNR2CNR1OPRM1TRPV1TRPM8
SCHEMBL23348482 0.87 OPRM1 (0.62) CNR2CNR1OPRM1TRPV1TRPM8
SCHEMBL24086354 0.86 CNR2 (0.60) CNR2CNR1OPRM1TRPV1TRPM8
SCHEMBL24626048 0.86 CNR2 (0.69) CNR2CNR1OPRM1TRPV1TRPM8
SCHEMBL24625925 0.86 CNR2 (0.69) CNR2CNR1OPRM1TRPV1TRPM8
SCHEMBL4860940 0.86 CNR2 (0.67) CNR2CNR1OPRM1TRPV1TRPM8
SCHEMBL24625797 0.86 CNR2 (0.69) CNR2CNR1OPRM1TRPV1TRPM8
SCHEMBL25192923 0.86 CNR2 (0.67) CNR2CNR1OPRM1TRPV1TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220183998-A1 USE OF 8,9- DIHYDROCANNABIDIOL COMPOUNDS UNIV CALIFORNIA (US) 2022-06-16 US disclosed
US-20210093724-A1 TOPICAL ANTI-ACNE COMPOSITION CONCEPT MATRIX SOLUTIONS 2021-04-01 US disclosed
US-20210093529-A1 TOPICAL SUNSCREEN CONCEPT MATRIX SOLUTIONS 2021-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210093724-A1 TOPICAL ANTI-ACNE COMPOSITION CUTA, EBP, CNR2 CNR2 3/4885CNR1 4/4885OPRM1 2225/4885
US-20210093529-A1 TOPICAL SUNSCREEN SUN2, CYP51A1, DSG1 CNR2 10/4885CNR1 20/4885OPRM1 4425/4885
US-20220183998-A1 USE OF 8,9- DIHYDROCANNABIDIOL COMPOUNDS CNR2, CACNA1B, CNR1 CNR2 1/4885CNR1 3/4885OPRM1 2579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.